|
|
|
Total Number of Holdings (excluding cash): 51
Masimo Corporation |
MASI |
574795100 |
649 |
$93,767.52 |
2.92% |
DexCom, Inc. |
DXCM |
252131107 |
660 |
$92,056.80 |
2.87% |
Shockwave Medical, Inc. |
SWAV |
82489T104 |
261 |
$84,201.21 |
2.63% |
Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
622 |
$80,412.76 |
2.51% |
Terumo Corporation |
4543.JP |
J83173104 |
2,030 |
$75,547.01 |
2.36% |
Intuitive Surgical, Inc. |
ISRG |
46120E602 |
184 |
$73,618.40 |
2.30% |
Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
255 |
$72,421.69 |
2.26% |
ResMed Inc. |
RMD |
761152107 |
358 |
$70,286.14 |
2.19% |
Stryker Corporation |
SYK |
863667101 |
195 |
$69,948.45 |
2.18% |
Boston Scientific Corporation |
BSX |
101137107 |
1,015 |
$69,649.30 |
2.17% |
Waters Corporation |
WAT |
941848103 |
199 |
$68,692.81 |
2.14% |
Cochlear Limited |
COH.AU |
Q25953102 |
310 |
$68,221.15 |
2.13% |
Edwards Lifesciences Corporation |
EW |
28176E108 |
711 |
$67,651.65 |
2.11% |
GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
748 |
$67,551.88 |
2.11% |
Baxter International Inc. |
BAX |
071813109 |
1,579 |
$67,407.51 |
2.10% |
Agilent Technologies, Inc. |
A |
00846U101 |
454 |
$66,905.98 |
2.09% |
Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
496 |
$67,138.22 |
2.09% |
Demant A/S |
DEMANT.DC |
K3008M105 |
1,293 |
$64,384.08 |
2.01% |
Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
4,063 |
$64,433.62 |
2.01% |
Insulet Corporation |
PODD |
45784P101 |
379 |
$64,119.22 |
2.00% |
Mettler-Toledo International Inc. |
MTD |
592688105 |
48 |
$64,120.32 |
2.00% |
Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
481 |
$63,785.41 |
1.99% |
Amplifon SpA |
AMP.IM |
T0388E118 |
1,726 |
$63,633.83 |
1.98% |
Abbott Laboratories |
ABT |
002824100 |
553 |
$62,754.44 |
1.96% |
The Cooper Companies, Inc. |
COO |
216648501 |
616 |
$62,733.44 |
1.96% |
Veralto Corporation |
VLTO |
92338C103 |
700 |
$62,818.00 |
1.96% |
Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
391 |
$62,663.74 |
1.95% |
Hoya Corporation |
7741.JP |
J22848105 |
494 |
$62,342.25 |
1.94% |
Align Technology, Inc. |
ALGN |
016255101 |
189 |
$61,973.10 |
1.93% |
Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,008 |
$61,534.08 |
1.92% |
Medtronic Plc |
MDT |
G5960L103 |
699 |
$60,757.08 |
1.89% |
Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
208 |
$60,463.13 |
1.89% |
Danaher Corporation |
DHR |
235851102 |
240 |
$59,704.80 |
1.86% |
Thermo Fisher Scientific Inc. |
TMO |
883556102 |
103 |
$59,675.11 |
1.86% |
Teleflex Incorporated |
TFX |
879369106 |
265 |
$59,325.55 |
1.85% |
Penumbra, Inc. |
PEN |
70975L107 |
256 |
$57,953.28 |
1.81% |
Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,377 |
$57,720.21 |
1.80% |
BioMerieux |
BIM.FP |
F1149Y232 |
520 |
$56,978.90 |
1.78% |
Hologic, Inc. |
HOLX |
436440101 |
729 |
$56,388.15 |
1.76% |
Alcon Inc. |
ALC.SW |
H01301128 |
670 |
$55,703.15 |
1.74% |
Olympus Corporation |
7733.JP |
J61240107 |
3,840 |
$55,452.15 |
1.73% |
DENTSPLY SIRONA Inc. |
XRAY |
24906P109 |
1,630 |
$54,295.30 |
1.69% |
Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,670 |
$54,303.71 |
1.69% |
Sysmex Corporation |
6869.JP |
J7864H102 |
978 |
$53,240.69 |
1.66% |
Exact Sciences Corporation |
EXAS |
30063P105 |
771 |
$51,564.48 |
1.61% |
West Pharmaceutical Services, Inc. |
WST |
955306105 |
130 |
$51,233.00 |
1.60% |
Steris Plc |
STE |
G8473T100 |
226 |
$50,967.52 |
1.59% |
Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
145 |
$50,686.20 |
1.58% |
Revvity, Inc. |
RVTY |
714046109 |
475 |
$50,069.75 |
1.56% |
Becton, Dickinson and Company |
BDX |
075887109 |
195 |
$48,073.35 |
1.50% |
WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,978 |
$18,735.71 |
0.58% |
US Dollar |
$USD |
|
6,911 |
$6,911.09 |
0.22% |
Australian Dollar |
$AUD |
|
564 |
$368.65 |
0.01% |
Euro |
$EUR |
|
103 |
$111.13 |
0.00% |
Pound Sterling |
$GBP |
|
0 |
$0.06 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|